SCHEDULE: Wellington Hadley Harbor Divests Beta Bionics Stake

Sentiment:

Beneficial Ownership Report


Wellington Hadley Harbor Aggregator IV, L.P. reports 0% beneficial ownership in Beta Bionics, Inc. common stock.

Summary

  • Wellington Hadley Harbor Aggregator IV, L.P. filed an Amendment No. 2 to Schedule 13G regarding its holdings in Beta Bionics, Inc.
  • The reporting person now beneficially owns 0 shares of Beta Bionics, Inc. common stock.
  • This represents 0.0% of the class of securities.
  • The filing indicates no sole or shared voting or dispositive power over any shares as of December 31, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing as it simply reports a change in beneficial ownership to zero, without providing specific reasons or implications for the issuer's operations or financial health.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that institutional investor filings like Schedule 13G provide transparency into significant ownership changes, which can sometimes signal shifts in investor sentiment or portfolio rebalancing within the biotechnology or medical device industry, where Beta Bionics operates.

Stakeholder Impact

  • The divestment by Wellington Hadley Harbor Aggregator IV, L.P. means that Beta Bionics, Inc. no longer has this entity as a beneficial owner, potentially impacting the shareholder base composition.

Key Dates

DateDescription
12/31/2025Date of event which requires filing of this statement, indicating the reporting person's beneficial ownership became 0%.
02/10/2026Date the Schedule 13G Amendment No. 2 was signed.

Recommendation

hold

This filing is a routine disclosure of an institutional investor's complete divestment of its stake. It does not provide new information about Beta Bionics' operational performance, strategic direction, or financial health that would warrant a change in investment recommendation based solely on this document. Investors should consider this a neutral event and look to other filings for fundamental analysis.

Keywords

Beta Bionics, Wellington Hadley Harbor, Schedule 13G, Common Stock, Beneficial Ownership, Divestment, Institutional Investor

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.